Literature DB >> 16965942

Epigenetics, disease, and therapeutic interventions.

Q Lu1, X Qiu, N Hu, H Wen, Y Su, B C Richardson.   

Abstract

Heritable changes in gene expression that do not involve coding sequence modifications are referred to as "epigenetic". Epigenetic mechanisms principally include DNA methylation and a variety of histone modifications, of which the best characterized is acetylation. DNA hypermethylation and histone hypoacetylation are hallmarks of gene silencing, while DNA hypomethylation and acetylated histones promote active transcription. Aberrant DNA methylation and histone acetylation have been linked to a number of age related disorders including cancer, autoimmune disorders and others. Since epigenetic alterations are reversible, modifying epigenetic marks contributing to disease development may provide an approach to designing new therapies. Herein we review the role of epigenetic changes in disease development, and recent advances in the therapeutic modification of epigenetic marks.

Entities:  

Mesh:

Year:  2006        PMID: 16965942     DOI: 10.1016/j.arr.2006.07.001

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  33 in total

1.  Intervention, integration and translation in obesity research: Genetic, developmental and metaorganismal approaches.

Authors:  Maureen A O'Malley; Karola Stotz
Journal:  Philos Ethics Humanit Med       Date:  2011-01-28       Impact factor: 2.464

Review 2.  Basic concepts of epigenetics: impact of environmental signals on gene expression.

Authors:  Elizabeth A Mazzio; Karam F A Soliman
Journal:  Epigenetics       Date:  2012-02       Impact factor: 4.528

Review 3.  Epigenetic mechanisms in anti-cancer actions of bioactive food components--the implications in cancer prevention.

Authors:  B Stefanska; H Karlic; F Varga; K Fabianowska-Majewska; Ag Haslberger
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo.

Authors:  Fawzia Bardag-Gorce; Jennifer Dedes; Barbara A French; Joan V Oliva; Jun Li; Samuel W French
Journal:  Exp Mol Pathol       Date:  2007-03-30       Impact factor: 3.362

5.  Methylated DNA immunoprecipitation.

Authors:  Kelsie L Thu; Emily A Vucic; Jennifer Y Kennett; Cameron Heryet; Carolyn J Brown; Wan L Lam; Ian M Wilson
Journal:  J Vis Exp       Date:  2009       Impact factor: 1.355

Review 6.  Developmental influences on medically unexplained symptoms.

Authors:  C A Tony Buffington
Journal:  Psychother Psychosom       Date:  2009-03-09       Impact factor: 17.659

7.  Identification of novel small molecule activators of nuclear factor-κB with neuroprotective action via high-throughput screening.

Authors:  Marina S Manuvakhova; Guyla G Johnson; Misti C White; Subramaniam Ananthan; Melinda Sosa; Clinton Maddox; Sara McKellip; Lynn Rasmussen; Krister Wennerberg; Judith V Hobrath; E Lucile White; Joseph A Maddry; Maurizio Grimaldi
Journal:  J Neurosci Res       Date:  2011-01       Impact factor: 4.164

8.  Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.

Authors:  Zhaofei Yang; Xuan Wang; Jian Yang; Min Sun; Yong Wang; Xiaomin Wang
Journal:  Neurotox Res       Date:  2016-12-15       Impact factor: 3.911

9.  Aminoglycoside-induced histone deacetylation and hair cell death in the mouse cochlea.

Authors:  Fu-Quan Chen; Jochen Schacht; Su-Hua Sha
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

10.  Epigenetic perturbations in the pathogenesis of mustard toxicity; hypothesis and preliminary results.

Authors:  Ahmet Korkmaz; Hakan Yaren; Z Ilker Kunak; Bulent Uysal; Bulent Kurt; Turgut Topal; Levent Kenar; Ergun Ucar; Sukru Oter
Journal:  Interdiscip Toxicol       Date:  2008-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.